Navigation Links
CHMP Recommends Approval of BYETTA® for Use With Basal Insulin
Date:2/17/2012

g food. Antibodies may develop with use of BYETTA. Patients who develop high titers to exenatide could have worsening or failure to achieve adequate glycemic control. Severe allergic reactions can happen with BYETTA. There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug.

The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation and weakness. Nausea most commonly happens when first starting BYETTA, but may become less over time.

These are not all the side effects from use of BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For additional important safety information about BYETTA, please see the full Prescribing Information (www.BYETTA.com/pi) and Medication Guide (www.BYETTA.com/mg).

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin is committed to delivering novel therapies that transform the way diabetes, obesity and related metabolic disorders are treated. Amylin is headquartered in San Diego and has a commercial manufacturing facility in Ohio. More information about Amylin Pharmaceuticals is available at www.amylin.com.

About Lilly

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continue
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc. and Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
2. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
5. Task Force Recommends Screening for Hearing Loss in All Newborns
6. CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
7. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
8. CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
9. Independent Data Monitoring Committee Recommends Resuming Enrollment of Non-Squamous NSCLC Patients in the Motesanib MONET1 Trial
10. Task Force Recommends Using Aspirin to Prevent Cardiovascular Disease When the Benefits Outweigh the Harms
11. FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... KUALA LUMPUR, Malaysia , April 20, 2015 /PRNewswire/ ... 2015, resulting in a scarcity of opportunities for generic ... drug manufacturers in the region are looking beyond the ... the quality of existing drugs. Certain established generic manufacturers ... research and development of new molecules, although the impact ...
(Date:4/20/2015)... Dr. Gregory Taylor , Canada,s Chief ... after spending a week in West Africa . ... needs on the ground as global efforts continue to reach zero ... prevention efforts in Sierra Leone and ... first-hand the work being done and hear from those on the ...
(Date:4/20/2015)... 20, 2015 Actavis plc (NYSE: ... Mayr , Chief Communications Officer, will retire from ...  In conjunction with Mayr,s retirement, Alex Kelly ... of Chief Communications Officer, effective immediately. Prior to ... Vice President, Chief Communications Officer, Public Affairs and ...
Breaking Medicine Technology:Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5Canada's Efforts Making a Difference in the Fight Against Ebola 2Canada's Efforts Making a Difference in the Fight Against Ebola 3Canada's Efforts Making a Difference in the Fight Against Ebola 4Canada's Efforts Making a Difference in the Fight Against Ebola 5Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3
(Date:4/21/2015)... Optimity Advisors ( Optimity), ... that helps clients in complex industries navigate rapid ... Association of Community Affiliated Plans (ACAP) ... 58 local, not-for-profit, community-affiliated Safety Net Health Plans ... primarily enrolled in public or state-sponsored coverage programs, ...
(Date:4/21/2015)... 2015 When a bandage sticks to ... In order to solve this problem two inventors from ... This improved bandage helps a cut, burn, abrasion or ... enhances air exposure. The bandage is easy to use, ... design was submitted to the St. Louis office of ...
(Date:4/21/2015)... April 21, 2015 NOVAtime Technology, ... enterprise Time and Attendance / Workforce Management solutions, ... from the American Payroll Association (APA) as well ... The APA has been the nation’s payroll authority ... networking opportunities, and recertification credits. Held at the ...
(Date:4/21/2015)... DC (PRWEB) April 21, 2015 ... announce the launch of Medicare-Medicaid Dual Eligibles Database, ... focuses on care provided to the more than ... who account for more than $300 billion in ... researchers – the same team that also creates ...
(Date:4/21/2015)... 2015 One of the most difficult ... meal food cravings. Many diets end badly due to ... meals. Some attempt to eat more often throughout the ... more regular intervals. While this approach does work for ... directly after a meal. For those who are having ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 3Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3
... NEW YORK, June 24 Twinlab is proud to announce the ... J. Aaron Memorial Mighty Montauk Triathlon. With winners in most divisions, ... The race consisted of a 1 mile swim, 22 mile bike ... the team, Andrew Kalley placed second and for her first win, ...
... , WASHINGTON, June 24 Attorney General Eric Holder, Health and Human ... will announce a law enforcement action related to the Health Care Fraud ... WEDNESDAY, JUNE 24, at 12:30 P.M. ET. , ... Human Services Secretary Kathleen Sebelius , FBI Director Robert S. Mueller, ...
... LifeSculpt is minimally-invasive and offers a faster recovery ... Mass., June 24 ... developer for cosmetic treatments, announced today the nationwide ... LifeSculpt features the SlimLipo laser body sculpting technology, ...
... and largest provider of retail health care in the ... provider in all insurance plans offered by CareFirst BlueCross ... CareFirst is the largest health care insurer in ... a participating provider with CareFirst,s preferred provider and federal ...
... , SALT LAKE CITY, June 24 Dynatronics Corporation ... shipping its new V-Force Vibration Therapy units to customers. ... provides neuromuscular training to increase strength, improve balance and ... Russian space program to compensate for bone and muscle ...
... , HARRISBURG, Pa., June 24 According to the ... Of that number, unfortunately, 5.7 million people are unaware ... parts of the body, including the kidneys, nerves, heart ... diabetics are more prone to several oral health problems, ...
Cached Medicine News:Health News:Team Full Throttle Twinlab(R) Racing Nabs Podiums in Several Divisions at the 2009 Robert J. Aaron Memorial Mighty Montauk Triathlon 2Health News:Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment 2Health News:Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment 3Health News:Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment 4Health News:MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 2Health News:MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans 3Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 2Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 3Health News:Diabetes: It's Connection to Oral Health 2Health News:Diabetes: It's Connection to Oral Health 3
Latex agglutination slide test for the qualitative and semi-qualitative detection of antinuclear antibodies to aid in the diagnosis of systemic lupus erthyematosus....
Color-enhanced slide test for the rapid qualitative and semi-quantitative detection of antibodies to streptococcal extracellular antigens in serum, plasma and peripheral blood....
Latex agglutination slide test to aid in the identification of Staphylococcus aureus colonies from culture media....
Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
Medicine Products: